Lung cancer diagnosed following emergency admission: a mixed methods study protocol to improve understanding of patients’ characteristics, needs, experiences and outcomes by Wilcock, A. et al.
Wilcock et al. BMC Palliative Care 2013, 12:24
http://www.biomedcentral.com/1472-684X/12/24STUDY PROTOCOL Open AccessLung cancer diagnosed following emergency
admission: a mixed methods study protocol to
improve understanding of patients’
characteristics, needs, experiences and outcomes
Andrew Wilcock1,2*, Vincent Crosby2, Sarah Freer2, Alison Freemantle2, Glenys Caswell3 and Jane Seymour3Abstract
Background: Lung cancer is the leading cause of death from cancer in England. About 40% of patients with lung
cancer are diagnosed following an emergency admission (DFEA) to hospital. DFEA is more common in women, and
more likely with increasing age and deprivation. Most have advanced disease and survival is poor, but little else is
known about this group. The aim of this study is to obtain a detailed understanding of the characteristics, needs,
experiences and outcomes of this group.
Methods/Design: This is a single centre study with quantitative and qualitative work packages (WP). WP1 gathers
basic details about all patients diagnosed with lung cancer during a 12 month period, focusing on demographics,
diagnostic and treatment pathways and selected outcomes. WP2 obtains information from those patients DFEA or,
when unable, their carers, about their holistic needs and experiences, using the Sheffield Profile for Assessment and
Referral to Care questionnaire and selected questions from the National Cancer Patient Experience Survey. WP3
uses in-depth qualitative interviews with patients and carers to obtain detailed accounts of their symptoms, help-
seeking behaviours prior to admission and subsequent experiences of care.
Discussion: Relatively little is known about the experiences of lung cancer patients DFEA and this study will
provide detailed information about their needs, characteristics, experiences and outcomes. It should identify areas
in the diagnostic and treatment pathway where there is scope to improve the care provided to this group of
patients and their carers. The findings will also inform the need for further focused research.
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Lung cancer is the leading cause of death from cancer in
England. Prognosis is poor, with one and five year sur-
vival rates lower than found in some other countries, in
part because of the high proportion of patients presen-
ting with advanced, incurable disease [1,2]. Indeed, about
40% of patients with lung cancer are diagnosed following
an emergency admission (DFEA) to hospital, the highest
of any cancer. Survival is particularly poor for this group* Correspondence: andrew.wilcock@nottingham.ac.uk
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reproduction in any medium, provided the or(9% vs. 26% overall at one year) with most having
advanced disease. DFEA is more common in women, and
more likely with increasing age and deprivation [3,4].
However, relatively little else is known about this group.
This paper presents a study protocol of a research
project seeking to identify the characteristics, needs,
experiences and outcomes of patients with lung cancer
DFEA. In-depth interviews with patients and their infor-
mal carers will also explore beliefs, expectations and
behaviours prior to diagnosis and what encounters they
report with health services prior to the admission.
We anticipate that the study findings will help to iden-
tify areas of practice where improvements can be madel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patients and their carers.
Methods/Design
Study aim and objectives
Aim
1. To obtain a detailed understanding of the
characteristics, needs, experiences and outcomes of
patients with lung cancer who are DFEA to identify
areas in the diagnostic and treatment pathway where
there is scope to improve the care provided to this
group of patients and their carers.
Objectives
1. To compare basic demographic details, the steps
and time taken through the diagnostic and
treatment pathway, and selected outcomes of
patients DFEA and those not-DFEA.
2. To obtain from patients DFEA and/or their informal
carers, information about their holistic needs and
experiences using the Sheffield Profile for
Assessment and Referral to Care (SPARC©)
questionnaire and questions from the National
Cancer Patient Experience Survey.
3. To obtain a detailed account of the experience of
symptoms and help-seeking behaviours prior to
admission and overall care provided by interviewing
in depth up to 30 patients DFEA and their carers.
4. To identify areas in the diagnostic and treatment
pathway where there is scope to improve the care
provided to patients DFEA and their informal carers.
5. To inform the focus of future research.
This is a single centre, prospective mixed methods
study. The research setting is a large University Hospital
National Health Service Trust in England and the pro-
ject comprises of three work packages, two using quanti-
tative methods of data collection and one employing
qualitative methods. Mixed methods research is that in
which ‘the investigator collects and analyses data, inte-
grates the findings, and draws inferences using both
qualitative and quantitative approaches or methods in a
single study or a program of inquiry’ [5]. Such research
takes a pragmatic philosophical and methodological
stance in order to address to real world problems.
Work package 1
This involves the identification of all patients with lung
cancer through the hospital's lung cancer multidiscipli-
nary team meeting (LC-MDT), and collecting informa-
tion from their hospital records. Over one year, all
patients assigned a histological or clinical diagnosis of lungcancer at the two lung cancer multidisciplinary team (LC-
MDT) meetings held weekly at the study centre, will be
identified by the research team in conjunction with colla-
borators and the lung cancer nurse specialists and
categorised as DFEA or not-DFEA. As quasi-anonymised
data, similar to that collected as part of the National Lung
Cancer Audit, there is no need to obtain informed consent
for this work package [6].
The following data will be collected for all patients:
age, gender, ethnicity, performance status (Eastern Co-
operative Oncology Group Scale) [7], postcode (recorded
as a lower super-output area code to produce a deprivation
score), whether seen by a lung cancer nurse specialist at
diagnosis or not, diagnostic investigations undertaken
(type and timing from referral to secondary care), histo-
logical type and stage of lung cancer, time from referral to
secondary care to discussion at LC-MDT, treatment rec-
ommendation of LC-MDT, treatment received and time
from LC-MDT, hospital days utilised, discharge desti-
nation, outcome (survival or place of death).
This work package will provide information on the
demographics, navigation through the diagnostic and
treatment pathway, and outcomes for patients DFEA, and
permit comparison with patients who are not-DFEA.Inclusion and exclusion criteria for work packages 2 and 3
All adult patients with lung cancer DFEA are potentially
eligible to participate in the questionnaires and the in-
depth interview. When a patient is unable to participate,
e.g. because of being too unwell, an adult carer will be
approached and invited instead. Exclusion criteria are
patients and carers who are: experiencing severe distress;
who lack capacity to consent or awareness of the diagno-
sis of lung cancer or are who are unable to communicate
in English.Work package 2
All adult patients with lung cancer DFEA identified in
work package 1 will be potentially eligible. When the
patient is unable to take part, e.g. because of being too
unwell, their main carer will be approached instead.
After providing an information sheet for a minimum of
24 hours, if they agree to take part, written informed
consent will be obtained by a member of the research
team. The Charlson co-morbidities index is completed
and the patient (or carer) will be asked to complete the
Sheffield Profile for Assessment and Referral to Care
(SPARC©) questionnaire [8-10] and selected items from
the 2012 National Cancer Patient Experiences Survey
(NCPES) [11]. Questions in the NCPES which relate to
information already collected or are irrelevant to this
group have been removed. Patients or their carers will
only need to complete the questionnaires once.
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performance status, co-morbidity, holistic needs and
experiences of patients who are DFEA. The potential inte-
rest of the patient or carer in taking part in the in-depth
interview several weeks later (work package 3) is gauged
and consent obtained to contact them subsequently.
Work package 3
Until recruitment is complete, all patients DFEA and
carers who take part in work package 2 will be offered the
opportunity to take part in an exploratory qualitative
interview, and those indicating a willingness to be invol-
ved will receive an information sheet. Subsequently they
will be contacted by the Research Assistant and if they
agree to take part, written informed consent will be
obtained. The qualitative interviews are designed to obtain
an understanding of their experiences prior to emergency
admission, especially with regards to symptoms and
problems experienced. The interview also explores their
narratives of the overall care experienced since emergency
admission. The interviews will take place several weeks
after discharge from hospital. Some patients are likely to
die in hospital or shortly after discharge; if so, their infor-
mal carers will be approached for interviews at least
6 weeks after bereavement.
We will seek to undertake interviews [12] with pa-
tients and carers separately, although some may prefer
to be interviewed together. Each interview will be person
centred, with questioning taking a flexible format guided
by an aide memoire [13]. Participants will be encouraged
to recount their experiences in their own terms [14].
Arrangements will be made to follow up issues raised in
the interviews, such as unrelieved symptoms or pro-
blems in bereavement, with participants’ permission and
in collaboration with the responsible clinical teams.
Sample size
The number of patients diagnosed with lung cancer over
a 12 month period will be about 400, with about 150 of
these DFEA. This permits an estimate of the precision of
any values found in work package 1 when applied to a
population level. For the sample sizes of 150 and 250,
the two-sided 95% confidence intervals for any observed
percentage proportion for any question will not exceed 8
or 6% respectively, when a large sample normal approxi-
mation is used [15].
To test for differences in proportions between the two
groups, using an alpha of 0.05 we will have 90% power to
detect differences of, for example, 10% vs. 22%, 20% vs.
35%, and 30% vs. 46%, and 80% power to detect differ-
ences of 10% vs. 20%, 20% vs. 33%, and 30% vs. 44% [16].
A one year period of recruitment should also identify
a reasonable number of patients DFEA for work package
2, and ensure that sufficient patients and carers arerecruited on time to complete work package 3. Typically,
no more than 15 subjects are required to reach data
saturation, i.e. no new issues are elicited. Thus, up to 15
patients and 15 carers will be recruited to work package 3.
Participant withdrawal
It is explained to all potential participants (patients and
carers) that entry into the trial is entirely voluntary and
that their (or their relative’s) treatment and care will not
be affected by their decision. It is also explained that
they can withdraw at any time. In the event of their
withdrawal it is explained that their data collected so far
cannot be erased and we will use the data in the final
analyses where appropriate.
Data analysis
Work package 1
The research team will analyse these data using parame-
tric and non-parametric descriptive and comparative
statistics as appropriate. Kaplan and Meier survival
curves will be compared using the log-rank test. All cal-
culations will be performed using Statistical Package for
the Social Sciences (version 18) with a P value of <0.05
considered statistically significant.
Work package 2
The research team will analyse these data using ap-
propriate descriptive statistics. All calculations will be
performed using Statistical Package for the Social Sciences
(version 18).
Work package 3
Data collected from the interviews will be analysed by a
grounded theory perspective [17], so that attention is
focused on the systematic comparison between issues in
interviews with patients who are likely to be typical of
those DFEA and their carers. Interviews will be
recorded, transcribed and entered into a qualitative data
analysis package. Coding and thematic analysis will be
undertaken by two researchers to check validity. Stan-
dard procedures for evaluating rigour in qualitative
research will be employed [18].
Ethical aspects
This study will involve patients and their carers at a
stressful time and issues may be raised which require
sensitive handling. We will address this through the use
of experienced research and specialist nursing staff
(Work packages 2 and 3). They will be able to deal with
any issues appropriately and ensure that the responsible
clinical team are made aware of any need for additional
support.
Patient and carer participants completing the ques-
tionnaires are advised that the questionnaires have been
Wilcock et al. BMC Palliative Care 2013, 12:24 Page 4 of 5
http://www.biomedcentral.com/1472-684X/12/24used and found acceptable by people recently diagnosed
with cancer. Nonetheless, they could find some of the
questions upsetting or difficult to answer and if this were
the case they would not have to answer the question(s).
If they are left with any concerns as a result of taking
part in the study we would, with their permission,
inform the clinical team looking after them so that they
could provide them with appropriate support.
Similarly, patient and carer participants taking part
in the interviews are advised that they could find some
of the questions asked during the interview upsetting
or difficult to answer. If this were the case they would
not have to answer the question(s). If they were left
with any concerns as a result of taking part in the
study, with their permission, we would inform the
clinical team looking after them so that they could
provide them with appropriate support. Further, pa-
tient and carer participants in work packages 2 and 3
are made aware that they may withdraw from the
study at any time.
Full approval has been obtained from Nottingham 1
Research Ethics Committee, along with the necessary
research governance approval from the appropriate
Trust.Discussion
The aim of this study is to obtain a detailed understanding
of the characteristics, needs, experiences and outcomes of
patients with lung cancer who are DFEA, and to identify
areas in the diagnostic and treatment pathway where there
is scope to improve the care provided to this group of pa-
tients and their carers.
The findings potentially will have wide ranging implica-
tions, involving approaches to achieve earlier diagnosis in
primary care to ensuring good end of life care to those
admitted with life-limiting complications of advanced dis-
ease. The study has several strengths and limitations asso-
ciated with its design but also challenges, such as the
potentially sensitive nature of its focus on an illness with
such a high mortality rate.Strengths
Relatively little is known about the experiences of lung
cancer patients DFEA and, by focusing specifically on this
group, this study will provide the most detailed informa-
tion to date about their needs, characteristics, experiences
and outcomes. The research team is comprised of special-
ist palliative care medical professionals, specialist palliative
care nurses, experienced research nurses and social scien-
tists. This mix of disciplines and backgrounds brings a
range of perspectives to the conduct of the study and the
analyses.Limitations
All patients with lung cancer DFEA are eligible to par-
ticipate in work packages 2 and 3. It is likely, however,
that some patients will be too ill to participate and may
die soon after diagnosis. Although not ideal, we have
tried to mitigate this by inviting a patient’s informal
carer to act as a proxy in these circumstances.
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